Private Equity
TVM Capital Life Science said Monday that it has raised more than $201.6 million in the final close of its latest fund, TVM Life Science Ventures VII.
1 min read · 06 October 2014
TVM Capital Life Science, a global venture capital firm with an office in Montréal, has closed its TVM Life Science Ventures VlI. Focusing on achieving human clinical proof-of-concept for early-stage drug development projects, Fund VII raised US$201.6 million from cornerstone investors Teralys Capital and Eli Lilly and Co, as well as the Business Development Bank of Canada (BDC), Minnesota Life Insurance Co, CD Venture, Fondaction CSN and a number of pharmaceutical companies. Fund VII targets 12 to 15 project-focused-companies and up to five traditional, syndicated venture capital investments. Earlier this year, it invested in Montréal's PRCL Research Inc, a special purpose company that develops pharmaceutical assets.
5 min read · 06 October 2014
UCG buys VCJ and Buyouts magazines, peHUB.com, peHUB Wire, peHUB Canada, Pratt’s Guide and the PartnerConnect series of events, including PartnerConnect West in Half Moon Bay
2 min read · 06 October 2014
Performance at IVP XII, Clarus Lifesciences II improves last year
2 min read · 06 October 2014
Nokia makes first investment in sector as corporate funds aim to jump into driver’s seat
4 min read · 06 October 2014
Canadian specialty pharmaceutical company Knight Therapeutics Inc (TSX: GUD) has agreed to commit EUR 19.5 million ($27.5 million) to the third life sciences fund managed by Dutch venture capital firm Forbion Capital Partners. The commitment, which follows an earlier commitment to a life sciences fund managed by Sectoral Asset Management, expands Knight's product sourcing strategy for the Canadian market, the company said. Knight plans to commit up to $130 million to this strategy. Forbion this month announced a first close of Forbion Capital Fund III CV at EUR 92 million ($129.6 million).
4 min read · 03 October 2014
Late-stage bets have paid off nicely for the Oregon Public Employees Retirement Fund, according to an analysis by affiliated publication Venture Capital Journal.
2 min read · 02 October 2014
Canadian venture capital firm Cycle Capital Management has launched a new accelerator for startups in clean technology sectors. Called Ecofuel, the accelerator will be led by Simon McDougall, who will be its CEO and head coach. Ecofuel, which will also be supported by partners Écotech Québec and Sustainable Development Technology Canada (SDTC), will manage a four-month training, networking and mentoring program and offer participating companies seed funding of up to $100,000. Its first cohort is scheduled for January 2015.
3 min read · 02 October 2014
Formation 8 has led a $17 million round for San Francisco-based fertility app Glow.
1 min read · 02 October 2014
San Francisco-based GoodData closed a $25.7 million Series E round, as the big data company has now raised more than $100 million in total funding.
1 min read · 02 October 2014
